In T-ALL, gain of function mutations of IL7Rα, which could be detected in about 10% of pediatric patients, resulted in the activation of PI3K/Akt/mTOR signaling [86,87]. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.